Mental Health Technologies (MHT) Patents SmarTest(TM) Technology

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Automate Behavioral Health and Substance Use Screening Through MHT’s SmarTest™ Platform.

AURORA, IL / ACCESSWIRE / February 20, 2024 / Mental Health Technologies (MHT) is excited to announce its patented technology, SmarTest™. This cutting-edge software is a game changer for behavioral health screening. Not only does this AI-based technology automate the entire testing process, but also automatically writes the results directly into any EMR and sends referrals to a behavioral health partner instantly.

What sets SmarTest™ apart?

SmarTest™ uses Machine Learning and is customizable based on your practice’s screening requirements. Your providers define when and how a patient should be screened for various behavioral health conditions. You can set your testing parameters based on a patient’s gender, age, previous test scores, appointment details, insurance, and more. Additionally, SmarTest™ can automatically write test scores into any EMR and indicate abnormal results. For example, if a patient indicated suicidal tendencies on the PHQ-9, those test results can be highlighted. A unique feature of SmarTest™ is the URL redirect – you can redirect patients to any URL upon assessment completion. It can be used for provider reviews, information about advanced treatment options, or can even redirect patients to the 988 Suicide Hotline.

How can MHT bridge the gap between primary care and behavioral health care?

With MHT’s SmarTest™ technology, our platform can ask patients conditional questions based on their responses to each question and overall test score. For example, if a patient scores 10+ on a PHQ-9, SmarTest™ can ask an additional question asking the patient if they would like to speak with a predetermined behavioral health partner. Upon obtaining consent from the patient, SmarTest™ can send the care coordinator an alert instantly. We understand that screening for behavioral health conditions can uncover a large patient population struggling with their mental health, so with our SmarTest™ technology, we are able to provide a seamless solution to help provide better care and health outcomes for patients.

Learn more about how MHT can automate the mental health & substance abuse screening process for health care providers at www.mhtech.com.

###

Contact Information

Ernie Wallerstein
MHT CEO
ernie@mhtech.com
630-240-0323

SOURCE: Mental Health Technologies

View the original press release on newswire.com.

Staff

Recent Posts

St. Baldrick’s Foundation Launches June Campaign to Honor Childhood Cancer Survivors and Support Lifesaving Research

Los Angeles, California--(Newsfile Corp. - June 3, 2025) - This National Cancer Survivor Month, St.…

1 hour ago

ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis

TOKYO, June 3, 2025 /PRNewswire/ -- ThinkCyte, a life science company pioneering advanced AI-powered cell…

1 hour ago

Healthie Launches Dev Assist: AI-Native Tooling for Rapid Healthcare App Development, Powered by the Model Context Protocol (MCP)

New open-source tool connects Healthie's GraphQL API to leading AI assistants via the Model Context…

1 hour ago

MATTERWORKS INC. SECURES SERIES A FUNDING TO ADVANCE MACHINE INTELLIGENCE FOR PREDICTIVE BIOLOGY

SOMERVILLE, Mass., June 3, 2025 /PRNewswire/ -- Matterworks, Inc., the category-defining pioneer unlocking unstructured molecular…

1 hour ago

Digital Pathology Market worth US$2.75 billion by 2030 with 13.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., June 3, 2025 /PRNewswire/ -- The global Digital Pathology Market, valued at US$1.29…

1 hour ago

Seven Corners Healthcare Invests in MobileOp4, Advancing Medical Access in Disasters and Rural Communities

CARMEL, Ind., June 3, 2025 /PRNewswire/ -- In further commitment to increasing health care access…

1 hour ago